Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma Metastatic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07128251
What this trial is testing

A Single-Arm, Multicenter, Exploratory Clinical Study of Transarterial Chemoembolization (TACE) Combined With Iparomlimab and Tuvonralimab Injection and Bevacizumab Injection for the Treatment of Unresectable, Non-Metastatic Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma (HCC)ImmunotherapyPD-1+2 more
Anhui Provincial Hospital 47
Testing effectiveness (Phase 2)Study completedNCT05359861
What this trial is testing

Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Coherus Oncology, Inc. 30
Not applicableUnknownNCT04825470
What this trial is testing

Liver Transplantation for Unresectable GIST Liver Metastases

Who this might be right for
Liver DiseasesLiver CancerLiver Metastases+25 more
Hospital Universitario Virgen de la Arrixaca 50
Testing effectiveness (Phase 2)Ended earlyNCT01832857
What this trial is testing

Phase 2 Safety, Tolerability and Efficacy Study of CPI-613 in Cancer Patients

Who this might be right for
Cancer
Cornerstone Pharmaceuticals 7
Testing effectiveness (Phase 2)UnknownNCT05396937
What this trial is testing

Efficacy and Safety of T+A+RAD in HCC

Who this might be right for
Hepatocellular Carcinoma
Fudan University 42
Early research (Phase 1)Study completedNCT00031681
What this trial is testing

7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)

Who this might be right for
Advanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more
National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)Looking for participantsNCT04634357
What this trial is testing

ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma

Who this might be right for
HepatoblastomaHepatocellular Carcinoma (HCC)Liver Neoplasms+3 more
Eureka Therapeutics Inc. 12
Early research (Phase 1)Study completedNCT04084067
What this trial is testing

Indocyanine Green (ICG) Guided Tumor Resection

Who this might be right for
Neoplastic DiseaseSolid Tumor
St. Jude Children's Research Hospital 215
Testing effectiveness (Phase 2)UnknownNCT00514930
What this trial is testing

Multicentre Prospective Clinical Trial for RFA Tumour Aspirator Treatment of Primary and Secondary Malignancies of the Liver

Who this might be right for
Liver Cancer
University of Thessaly
Not applicableUnknownNCT04443322
What this trial is testing

Durvalumab and Lenvatinib in Participants With Locally Advanced and Metastatic Hepatocellular Carcinoma ( Dulect2020-1 )

Who this might be right for
Liver CarcinomaLiver Transplant; Complications
RenJi Hospital 20
Not applicableStudy completedNCT05690451
What this trial is testing

Non-contrast Abbreviated MRI for Secondary Surveillance of HCC

Who this might be right for
Hepatocellular Carcinoma
Seoul National University Hospital 210
Early research (Phase 1)Study completedNCT02572687
What this trial is testing

Ramucirumab (LY3009806) Plus MEDI4736 in Participants With Advanced Gastrointestinal or Thoracic Malignancies

Who this might be right for
Gastric CancerGastroesophageal Junction AdenocarcinomaNon-Small Cell Lung Cancer+1 more
Eli Lilly and Company 85
Testing effectiveness (Phase 2)Study completedNCT00484211
What this trial is testing

Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
AGC Biologics S.p.A. 40